LifeTech TaqMan Integrates with Genedata Expressionist for Genomic Profiling
Thursday, November 15, 2012
Genedata partners with Life Technologies to expedite NGS data analysis and real-time PCR-based validation.
Caris Life Sciences Selects Illumina’s MiSeq® System
Friday, November 09, 2012
Collaboration enhances breadth and depth of therapeutic information to help oncologists better personalize cancer treatment.
CeGaT and Genomatix Finalists of Boston Children’s Hospital’s CLARITY Challenge
Friday, November 09, 2012
Free exomes project for six families and new variant analysis software.
Illumina Announces Winners of MiSeq® Grant Program
Thursday, November 08, 2012
Awards will accelerate original research in microbial ecology, neglected disease, and human health.
Cartagenia and Interactive Biosoftware Integrate Technologies
Wednesday, November 07, 2012
Interactive Biosoftware’s Alamut gene browser capabilities, Cartagenia BENCHlab next-generation sequencing platform to be sold as integrated solution.
Rubicon Partners with Diagenode for ChIP Sample Preparation
Monday, November 05, 2012
Combining Rubicon ThruPLEX™ and Diagenode technologies enables scientists to efficiently conduct high quality ChIP studies from small samples for NGS and array analysis.
Life Technologies Announces Third Quarter 2012 Results
Monday, November 05, 2012
Revenue for the third quarter was $911 million, a decrease of 1.9 percent over the $929 million reported for the third quarter of 2011. Excluding the impact of currency, revenue growth for the quarter was 1.4 percent compared to the same period of the prior year.
‘1000 Genomes Barrier' Broken
Thursday, November 01, 2012
A landmark project that has sequenced 1,092 human genomes from individuals around the world will help researchers to interpret the genetic changes in people with disease.
Good Start Genetics® Announces The Expansion of its NGS-Based Carrier Screening Service
Friday, October 26, 2012
The announcement means that Good Start Genetics' screening service, GoodStart Select™, now offers state-of-the-art testing for all 23 of the diseases recommended in guidelines set by the major medical societies.
|
|
|
|
|
|
